Pharmacological Management of Irritable Bowel Syndrome With Constipation
Summary of Recommendations
Video
Recommendation Grading
Disclaimer
Overview
Title
Pharmacological Management of Irritable Bowel Syndrome With Constipation
Authoring Organization
American Gastroenterological Association
Publication Month/Year
June 21, 2022
Supplemental Implementation Tools
Document Type
Guideline
Country of Publication
US
Document Objectives
Irritable bowel syndrome (IBS) is a common disorder of gut–brain interaction associated with significant disease burden. This American Gastroenterological Association guideline is intended to support practitioners in decisions about the use of medications for the pharmacological management of IBS-C and is an update of a prior technical review and guideline.
Inclusion Criteria
Male, Female, Adult, Older adult
Health Care Settings
Ambulatory
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Treatment, Management
Diseases/Conditions (MeSH)
D043183 - Irritable Bowel Syndrome
Keywords
irritable bowel syndrome (IBS), IBS, IBS-C, irritable bowel syndrome with constipation
Source Citation
Chang L, Sultan S, Lembo A, et al. AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation. Gastroenterology. 2022;163:118–136.